Replaces deficient growth hormone when an endocrinologist confirms an appropriate diagnosis and establishes a monitoring plan.
HORMONES, ENERGY & VITALITY / PRACTITIONER-GUIDED
Human growth hormone
EvidenceEvidence in contexti
RegulatoryProduct-specifici

Established for product-specific approved indications; healthy-aging and performance use in people without deficiency is not an approved or proven pathway.
Prescription required; diagnosis- and product-specific FDA indications
WHO MAY BE CONSIDERED
Eligibility starts with your complete health context.
- ✓Symptoms and formal endocrine testing support true growth-hormone deficiency
- ✓Pituitary history and alternative causes have been evaluated
- ✓IGF-1, glucose and adverse effects can be monitored
WHAT A PRACTITIONER REVIEWS
The information that shapes the decision.
- Pituitary history, provocative testing and IGF-1 context
- Cancer history, glucose status and intracranial pressure risk
- Sleep apnea, edema, joint symptoms and interacting hormone deficiencies
IMPORTANT SAFETY INFORMATION
Reasons treatment may not be appropriate.
- !Active malignancy and several acute critical illnesses are major contraindication or warning contexts.
- !Fluid retention, nerve compression, glucose intolerance and intracranial hypertension can occur.
- !A low-normal IGF-1 or desire for more muscle does not establish adult growth-hormone deficiency.
ORIGINAL SOURCES
Review the evidence behind the option.
YOUR NEXT STEP
Ready for a clinician-led plan?
Clinical review determines the appropriate next step. No treatment is guaranteed.
THE CARE PATH
We order your labs
A licensed clinician reviews results and recommends a plan
Rx sent directly to you when appropriate
Care depends on eligibility and clinical judgment. No prescription is guaranteed. This pathway is not a recommendation for the treatment or test discussed in this guide.
Start your lab reviewExplore free educational tools